#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1771833	Functional	Antagonist activity at human EP3 receptor expressed in CHO cells assessed as inhibition of PGE2-induced increase in intracellular calcium concentration after 1 hr by FLIPR assay	Homo sapiens	26	ALA1770146	cell-based format	Scientific Literature
2.	ALA1771834	ADME	Clearance in Sprague-Dawley rat at 1 mg/kg, iv and 2 mg/kg, po	Rattus norvegicus	3	ALA1770146	organism-based format	Scientific Literature
3.	ALA1771835	ADME	Half life in Sprague-Dawley rat at 1 mg/kg, iv and 2 mg/kg, po	Rattus norvegicus	3	ALA1770146	organism-based format	Scientific Literature
4.	ALA1771836	ADME	Dose normalized AUC in Sprague-Dawley rat at 2 mg/kg, po	Rattus norvegicus	3	ALA1770146	organism-based format	Scientific Literature
5.	ALA1771837	ADME	Oral bioavailability in Sprague-Dawley rat at 2 mg/kg	Rattus norvegicus	3	ALA1770146	organism-based format	Scientific Literature
6.	ALA1771838	Functional	Antagonist activity at dog EP3 receptor	Canis lupus familiaris	1	ALA1770146	assay format	Scientific Literature
7.	ALA1771839	Functional	Antagonist activity at rat EP3 receptor	Rattus norvegicus	1	ALA1770146	assay format	Scientific Literature
8.	ALA2038927	ADME	Oral bioavailability in Sprague-Dawley rat at 2 mg/kg	Rattus norvegicus	5	ALA2034937	organism-based format	Scientific Literature
9.	ALA2039029	Functional	Antagonist activity against human EP2 receptor expressed in CHO-K1 cells assessed as inhibition of cAMP production after 4 hrs by FRET signal in LANCE assay	Homo sapiens	1	ALA2034937	cell-based format	Scientific Literature
10.	ALA2039030	Functional	Antagonist activity at EP1 receptor in human U2OS cells expressing Gqi5 assessed as inhibition of PGE2-induced response after 24 hrs by FLIPR assay	Homo sapiens	2	ALA2034937	cell-based format	Scientific Literature
11.	ALA2039031	Functional	Antagonist activity at dog EP3 receptor expressed in human U2OS cells co-expressing Gqi5 assessed as inhibition of PGE2-induced response after 24 hrs by FLIPR assay	Canis lupus familiaris	1	ALA2034937	cell-based format	Scientific Literature
12.	ALA2039032	Functional	Inhibition of GR63799-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 3 mg/kg, id	Rattus norvegicus	1	ALA2034937	organism-based format	Scientific Literature
13.	ALA2039034	ADME	Drug metabolism in rat liver S9 fraction assessed as NADPH-dependent glutathione conjugate level at 10 uM after 30 mins by LC-MS/MS analysis	Rattus norvegicus	4	ALA2034937	subcellular format	Scientific Literature
14.	ALA2039035	ADME	Drug metabolism in human liver S9 fraction assessed as NADPH-dependent glutathione conjugate level at 10 uM after 30 mins by LC-MS/MS analysis	Homo sapiens	4	ALA2034937	subcellular format	Scientific Literature
15.	ALA2039036	Functional	Inhibition of GR63799-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 0.3 mg/kg, id	Rattus norvegicus	1	ALA2034937	organism-based format	Scientific Literature
16.	ALA2039037	Functional	Inhibition of PGE2-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 30 mg/kg, id	Rattus norvegicus	1	ALA2034937	organism-based format	Scientific Literature
17.	ALA2039038	Functional	Inhibition of acetic acid-induced decrease in bladder capacity in conscious spontaneously hypertensive overactive bladder rat model at 30 mg/kg, id	Rattus norvegicus	1	ALA2034937	organism-based format	Scientific Literature
18.	ALA2039039	Binding	Binding affinity to human EP3	Homo sapiens	1	ALA2034937	single protein format	Scientific Literature
19.	ALA2039040	ADME	Half life in Sprague-Dawley rat at 1 mg/kg, iv	Rattus norvegicus	5	ALA2034937	organism-based format	Scientific Literature
20.	ALA2039041	ADME	Clearance in Sprague-Dawley rat at 1 mg/kg, iv and 2 mg/kg, po	Rattus norvegicus	5	ALA2034937	organism-based format	Scientific Literature